Raising capital to discover, develop, and commercialize new drugs has always been a regular feature for life sciences companies, and the current environment of tight equity markets and lower company valuations has caused significant strains. In response, many European life sciences businesses are turning to non-dilutive financing options that have
Continue Reading Non-Dilutive Financing: The U.S. Trend Catching on in Europe’s Life Sciences SectorNancy Marie Rich
Nancy Marie is an associate in the firm’s New York office and is a member of the Corporate Practice Group. She advises clients in a range of corporate matters.